Basis: Four-quarter operating EBITDA / current FMP quote-based enterprise value × 100. Source: stored company filings and market data; unavailable inputs remain N/A.
The EBITDA yield is N/A as of 2026-10-06T21:22:07.442Z.
Calculation as of: 2026-10-06T21:22:07.442Z.
Quote observation: 2026-10-06T20:00:01.000Z. Amounts in USD. The price header may show a later quote.
FMP input reference: 5055be797218969f54b4ba6f74251721a3824cc5143f897fa443291008c6f72f
Historical values estimate market capitalization from statement-period weighted shares. Comparisons with the current quote-based value are approximate. Only filing versions delivered by FMP are available for the historical calculation.
EBITDA YIELD
N/A
Market Cap
$68.90M
EBITDA Yield
29.87%
TTM Avg
26.76%
3Y Avg
678.75%
5Y Avg
678.75%
Market Cap
$65.86M
EBITDA Yield
445.09%
TTM Avg
3466.62%
3Y Avg
3466.62%
5Y Avg
3466.62%
Market Cap
$69.61M
EBITDA Yield
0.38%
TTM Avg
3.41%
3Y Avg
4.41%
5Y Avg
3.27%
| NAME | MARKET CAP | EBITDA YIELD | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| iBio, Inc. (IBIO) | $67.52M | N/A | N/A | N/A | N/A |
| Fortress Biotech, Inc. (FBIO)vs › | $68.10M | N/A | N/A | N/A | N/A |
| Spero Therapeutics, Inc. (SPRO)vs › | $68.90M | 29.87% | 26.76% | 678.75% | 678.75% |
| Gossamer Bio, Inc. (GOSS)vs › | $65.87M | N/A | N/A | N/A | N/A |
| Cingulate Inc. (CING)vs › | $65.86M | 445.09% | 3466.62% | 3466.62% | 3466.62% |
| XBiotech Inc. (XBIT)vs › | $65.85M | N/A | N/A | N/A | N/A |
| Champions Oncology, Inc. (CSBR)vs › | $69.61M | 0.38% | 3.41% | 4.41% | 3.27% |
| Tiziana Life Sciences Ltd (TLSA)vs › | $70.63M | N/A | N/A | N/A | N/A |
| Alps Group Inc (ALPS)vs › | $64.18M | N/A | N/A | N/A | N/A |
| Gain Therapeutics, Inc. (GANX)vs › | $71.23M | N/A | N/A | N/A | N/A |
EBITDA Yield = TTM EBITDA / Enterprise Value
EBITDA yield is the inverse of EV/EBITDA, expressing trailing pre-interest, pre-tax operating cash generation as a percentage of enterprise value. Comparable across leverage levels; higher is cheaper. Not meaningful for banks and insurers.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
